doi:10.16150/j.1671-2870.2021.04.004

Abstract

CLC Number:

R541.4

Figures/Tables 3

References 27

[1]	Roth GA, Mensah GA, Fuster V. The global burden of cardiovascular diseases and risks: a compass for global action[J]. J Am Coll Cardiol, 2020,76(25):2980-2981. doi: 10.1016/j.jacc.2020.11.021 URL
[2]	GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019[J]. Lancet,2020, 396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9 URL
[3]	GBD 2019 Risk Factors Collaborators. Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disea-se Study 2019[J]. Lancet,2020, 396(10258):1223-1249. doi: 10.1016/S0140-6736(20)30752-2 URL
[4]	Roth GA, Mensah GA, Johnson CO, et al. Global burden of cardiovascular diseases and risk factors, 1990-2019: update from the GBD 2019 study[J]. J Am Coll Cardiol,2020, 76(25):2982-3021. doi: 10.1016/j.jacc.2020.11.010 URL
[5]	Vekemans J, Gouvea-Reis F, Kim JH, et al. The path to group a Streptococcus Vaccines: World Health Organization research and development technology roadmap and preferred product characteristics[J]. Clin Infect Dis, 2019,69(5):877-883. doi: 10.1093/cid/ciy1143 pmid: 30624673
[6]	Yu K, Lv J, Qiu G, et al. Cooking fuels and risk of all-cause and cardiopulmonary mortality in urban China: a prospective cohort study[J]. Lancet Glob Health, 2020,8(3):e430-e439.
[7]	中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2020概要[J]. 中国循环杂志, 2021,36(6):521-545.
[8]	Moran A, Zhao D, Gu D, et al. The future impact of popu-lation growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Po-licy Model-China[J]. BMC Public Health, 2008,8:394. doi: 10.1186/1471-2458-8-394 URL
[9]	Du X, Patel A, Anderson CS, et al. Epidemiology of cardiovascular disease in China and opportunities for improvement: JACC International[J]. J Am Coll Cardiol, 2019,73(24):3135-3147. doi: 10.1016/j.jacc.2019.04.036 URL
[10]	Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications[J]. Nat Rev Cardiol, 2019,16(4):203-212. doi: 10.1038/s41569-018-0119-4 URL
[11]	Yang G, Wang Y, Zeng Y, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet, 2013,381(9882):1987-2015. doi: 10.1016/S0140-6736(13)61097-1 URL
[12]	Zhou M, Wang H, Zeng X, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019,394(10204):1145-1158. doi: 10.1016/S0140-6736(19)30427-1 URL
[13]	Zhao D. Epidemiological features of cardiovascular di-sease in Asia[J]. JACC: Asia, 2021,1(1):1-13. doi: 10.1016/j.jacasi.2021.04.007 URL
[14]	李镒冲, 刘世炜, 曾新颖, 等. 1990-2016年中国及省级行政区心血管病疾病负担报告[J]. 中国循环杂志, 2019,34(8):729-740.
[15]	Liu S, Li Y, Zeng X, et al. Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 global Burden of disease study[J]. JAMA Cardiol, 2019,4(4):342-352. doi: 10.1001/jamacardio.2019.0295 URL
[16]	王文, 朱曼璐, 王拥军, 等. 《中国心血管病报告2012》概要[J]. 中国循环杂志, 2013,28(6):408-412.
[17]	Jiang B, Wang WZ, Chen H, et al. Incidence and trends of stroke and its subtypes in China: results from three large cities[J]. Stroke, 2006,37(1):63-68. pmid: 16306469
[18]	Zhang G, Yu C, Zhou M, et al. Burden of ischaemic heart disease and attributable risk factors in China from 1990 to 2015: findings from the global burden of disease 2015 study[J]. BMC Cardiovasc Disord,2018, 18(1):18. doi: 10.1186/s12872-018-0761-0 URL
[19]	Dai H, Much AA, Maor E, et al. Global, regional, and national burden of ischemic heart disease and its attributable risk factors, 1990-2017: results from the Global Burden of Disease Study 2017[J]. Eur Heart J Qual Care Clin Outcomes, 2020:qcaa076.
[20]	Krishnamurthi RV, Feigin VL, Forouzanfar MH, et al. Global and regional burden of first-ever ischaemic and haemorrhagic stroke during 1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet Glob Health, 2013,1(5):e259-e281.
[21]	GBD 2016 Lifetime Risk of Stroke Collaborators, Feigin VL, Nguyen G, et al. Global, regional, and country-specific lifetime risks of stroke, 1990 and 2016[J]. N Engl J Med,2018, 379(25):2429-2437. doi: 10.1056/NEJMoa1804492 URL
[22]	Li H, Ge J. Cardiovascular diseases in China: current status and future perspectives[J]. Int J Cardiol Heart Vasc, 2014,6:25-31.
[23]	GBD 2019 Tobacco Collaborators. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019[J]. Lancet,2021, 397(10292):2337-2360. doi: 10.1016/S0140-6736(21)01169-7 URL
[24]	Zhang M, Deng Q, Wang L, et al. Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults[J]. Int J Cardiol, 2018,260:196-203. doi: S0167-5273(17)32606-2 pmid: 29622441
[25]	Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000[J]. N Engl J Med, 2007,356(23):2388-2398. doi: 10.1056/NEJMsa053935 URL
[26]	Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000[J]. Circulation,2004, 109(9):1101-1107. doi: 10.1161/01.CIR.0000118498.35499.B2 URL
[27]	Lv J, Yu C, Guo Y, et al. Adherence to healthy lifestyle and cardiovascular diseases in the Chinese population[J]. J Am Coll Cardiol, 2017,69(9):1116-1125.

疾病	1990年		2016年
疾病	死亡例数（n）	年龄标化死亡率（/10万）	死亡例数（n）	年龄标化死亡率（/10万）
心血管疾病
中国	2 245 278	332.3	4 344 334	268.1
美国	875 094	256.1	880 574	150.5
西欧国家	1 658 229	271.5	1 341 334	122.3
缺血性心脏病
中国	580 578	88.9	1 735746	109.7
美国	605 597	176.9	520 595	88.4
西欧国家	939 500	153.8	656 552	60.7
脑卒中
中国	1 267 953	184.2	2 098 212	125.5
美国	145 028	42.0	168 049	28.5
西欧国家	451 247	73.2	326 258	29.2

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

Figures/Tables 3

References 27

Related Articles 10

Recommended Articles

Metrics

Comments

[1]	. [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(03): 239-244.
[2]	SHENG Hong, ZHANG Andi. Study on application of nutritional risk screening in hospitalized patients with chronic heart failure [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(02): 178-183.
[3]	WU Jie, FENG Yuanyuan, REN Yan, CAO Jiumei. Survey of risk factors of coronary heart disease in elderly patients with coronary angiography and establishment of relevant diagnostic model [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(02): 201-206.
[4]	ZHA Qing, YU Chenxi, LIU Ya, YANG Ling, YE Jiawen, LIU Yan. Preliminary study on the role of miR-16 in progression of coronary atherosclerosis and possible molecular mechanism [J]. Journal of Diagnostics Concepts & Practice, 2021, 20(01): 82-87.
[5]	LIU Shengjun, LIU Lili, ZHU Zhengbin, SUN Yi, ZHU Tianqi, FENG Shuo, CHEN Xin, QUAN Weiwei, ZHANG Ruiyan. Correlation of estimated glomerular filtration rate with incidence of in-stent restenosis in patients with drug-elu-ting stent [J]. Journal of Diagnostics Concepts & Practice, 2020, 19(03): 297-302.
[6]	LIU Shanshan, Niu Jingya, WANG Tiange, LI Mian, ZHAO Zhiyun, XU Yu, LU Jieli, XU Min, BI Yufang, ZHANG Di. Epidemiological investigation on cardiometabolic abnormalities in Songnan Community residents with type 2 diabetes [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(03): 323-328.
[7]	. [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(2): 237-240.
[8]	HUANG Xiaoyi, CAI Wei, SHU Shizhen, PANG Xiaofen. Correlation of glycosylated hemoglobin and fasting blood glucose level with severity of lesion in elderly patients with carotid artery atherosclerosis [J]. Journal of Diagnostics Concepts & Practice, 2019, 18(1): 82-85.
[9]	. [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(06): 664-667.
[10]	LING Yuan, WANG Shuhong, LIANG Wei, SHEN Linhui. Study on correlation of serum level of C1q tumor necrosis factor-related protein 1（CTRP1) with coronary atherosclerotic heart disease [J]. Journal of Diagnostics Concepts & Practice, 2017, 16(02): 199-203.